UBR4

E3 ubiquitin-protein ligase UBR4 · Q5T4S7 · UBR4 on Sugi Atlas →

0 patent compounds predicted against UBR4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBR4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis PHASE2/PHASE3UNKNOWN
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study PHASE2WITHDRAWN
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma PHASE2SUSPENDED
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease EARLY_PHASE1RECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome nanCOMPLETED
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Signaling Pathways Targeting Colorectal Cancer in Egypt nanCOMPLETED
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
Establishment of a Prospective Clinical-biological Database nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS nanCOMPLETED
Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults nanNOT_YET_RECRUITING
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome nanRECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Using Mobile Technology to Improve Self-Regulation nanCOMPLETED
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level nanENROLLING_BY_INVITATION
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a UBR4 binder may also engage these)

ProteinNameSimilarity
A2AN08 1.000 A2AN08 →
Q2TL32 1.000 Q2TL32 →
Q18892 0.999 Q18892 →
Q6CAD2 0.999 Q6CAD2 →
A1Z8X3 0.998 A1Z8X3 →
Q9BVR0 0.998 Q9BVR0 →
Q9SXA1 0.997 Q9SXA1 →
Q9SWA6 0.997 Q9SWA6 →
O88738 0.997 O88738 →
Q759B7 0.997 Q759B7 →
Q6P9N1 0.997 Q6P9N1 →
B9EJV3 0.997 B9EJV3 →
Q80UK8 0.996 Q80UK8 →
Q0P4G8 0.996 Q0P4G8 →
Q9VPF9 0.996 Q9VPF9 →
Q9XV66 0.996 Q9XV66 →
F5HGK9 0.996 F5HGK9 →
P0C723 0.996 P0C723 →
P0C722 0.996 P0C722 →
A5WUT8 0.995 A5WUT8 →
Q6NRW0 0.995 Q6NRW0 →
Q9CA89 0.995 Q9CA89 →
Q61WP7 0.995 Q61WP7 →
P03207 0.995 P03207 →
P03209 0.995 P03209 →
GEMIN4 Gem-associated protein 4 0.995 landscape →
Q8BKX6 0.995 Q8BKX6 →
O17213 0.995 O17213 →
P11824 0.995 P11824 →
F5HEU7 0.995 F5HEU7 →